Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon gamma receptor modulators
TargetsInterferon gamma receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNostrumStony Brook University School Of MedicineNyu Langone Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesNostrumStony Brook University School Of Medicine
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A